DLL3 as a potential diagnostic and therapeutic target in neuroendocrine neoplasms: A narrative reviewAnnarita Peddio, Alberto Servetto, Aldo Caltavituro et al.|Critical Reviews in Oncology/Hematology|2024Cited by 25
Rebound thymic hyperplasia and immune related adverse events: reality or fantasy—a case reportBianca Arianna Facchini, Margaret Ottaviano, Francesca Sparano et al.|Mediastinum|2024Cited by 0